Flaskdata - Observability for clinical data
0 likes1,152 views
The investor deck outlines the challenges in clinical trials, highlighting that 19% miss endpoints due to R&D failures and significant delays in data monitoring. It presents a solution for real-time clinical data observability and automated anomaly detection using AI, which offers fast responses and improves compliance. The market for connected wearable devices and internet of bodies (IoB) is projected to grow, with potential revenue based on a subscription model and significant market penetration forecasts by 2026.
Flaskdata - Observability for clinical data
- 1. Investor Deck December 2020 Collect | Detect | Act Observability for clinical data
- 2. Source: FDA Performance goals, Deloitte 2020 Global life sciences outlook, “Why clinical trial outcomes fail to translate into benefits for patients”, Heneghan et al Summer 2016. A WTF moment. 19% Of clinical trials miss their endpoints. R&D failure. Collect | Detect | Act 6-18 Months delay to market Pivotal study Paper & briefcase No data monitoring Manual data cleanup - 6 months 1MB data #corona-time
- 3. Observability problem in clinical data Collect | Detect | Act Data Events Observability gap Hours Months 6-18 Valid data? Custom solutions China, India, USA - 294M wearable devices, 27% YOY
- 4. Collect | Detect | Act Our key value proposition Data Events Automated detect & act on clinical data 1 Now isAnomaly: ’t' #observe-clinical-data Zero-admin clinical data anomaly detection in an open API
- 5. Collect | Detect | Act 1 Act Detect Collect 2 3 Data anywhere, anytime AI-driven event detection Same day response Same day delivery #coronatime
- 6. Collect | Detect | Act Collaborators HealthSuite digital platformSingHealth • 35 clinical trials • 3 FDA approvals • 9M signals • 11394 alerts • 6200 patients
- 7. Collect | Detect | Act The ratio of compliance with the protocol is extremely high, and with the real-time alerts, we fix patient issues in a ‘short-loop’. This is a wonderful feature, and it makes the difference between a futile study and a successful one”. Alon Ironi CEO, Theranica Therapeutics Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications. Rapoport et al. The Journal of Headache and Pain. Migraine treatment case study 5M patient/device signals NCT03361423 253 patients 95% compliance 5’ to endpoints (1) (1) 95% of patient data from migraine sessions is collected digitally from handset via BLE from wearable device and transmitted via Flask API to the Flask platform. A second API process on the platform computes endpoints like Photophobia and updates the EDC within 5’ after patient reports outcomes.
- 8. Collect | Detect | Act CHF case study Pickup payer data Collect | Detect Anomalies 647 Signals 3.1K
- 9. Observability for the world of IOB • Unsupervised anomaly detectionOne size Fits all • Affordable for connected device market • OpenAPI
- 10. Collect | Detect | Act Our TAM Identified segments Market data sources: 1. Statista USA 16% India 27% China 57% $5BN Internet of Bodies (IOB) observability market 100 733.333 1366.667 2000 2020 2021 2022 2023 1,403 1,105 929 835 Worldwide connected wearable devices (millions) Assumption: $3/endpoint/year
- 11. Collect | Detect | Act Jenya Konikov-Rozenman Co-founder. Delivery Duchenne researcher Danny Lieberman Founder. CEO Physicist & Serial entrepreneur Eugene Kalosha Architect PhD AI Research Rivka Rot Data pipeline Fraud & big data Dr Dan Peres Co-founder. Product Medical & clinical Why us?
- 12. Questions? Danny Lieberman - Founder & CEO dannyl@flaskdata.io
- 13. Collect | Detect | Act Forecast ARR 0 22.5 45 67.5 90 2022 2023 2024 2025 2026 58 23 12 21 Revenue(M) Market penetration 0.07% 0.33% 1.33% 2.0% 4.0% # of IOB 260K 1.56M 8M 15.3 38.85M • $3/endpoint/year • Subscription auto renew at 12 month • 50% to channel • Identified segments • CAGR 27% Assumptions